IQV

IQVIA Holdings Inc

278.32

Oct 22 • 3:59 PM ET +1.69 (0.61%)

278.75

Aftermarket • 7:31 PM ET +0.43 (0.15%)

Healthcare Diagnostics & Research USA Large NYSE

Peers: ICLR MEDP TMO LH FTRE CRL VEEV DHR TEM CERT

| Held by: VTI VOO VO IVV SPY VTV XLV VOE RSP IWR

Scroll to Statements

Index	S&P 500
Market Cap	45.81B
Enterprise Value	60.10B
Income	1.38B
Sales	16.99B
Book/sh	37.49
Cash/sh	12.64
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	93000
IPO	May 09, 2013

P/E	34.52
Forward P/E	19.37
PEG	1.84
P/S	2.70
P/B	7.42
P/C	22.02
P/FCF	20.98
EV/EBITDA	16.95
EV/Sales	3.54
Quick Ratio	0.71
Current Ratio	0.71
Debt/Eq	2.63
LT Debt/Eq	2.26
Option/Short	Yes / Yes

EPS (ttm)	8.06
EPS next Y	14.37
EPS next Q	3.26
EPS this Y	8.59%
EPS next Y	11.00%
EPS next 5Y	10.50%
EPS past 3/5Y	11.05% 40.52%
Sales past 3/5Y	4.18% 7.50%
EPS Y/Y TTM	16.68%
Sales Y/Y TTM	8.22%
EPS Q/Q	-0.36%
Sales Q/Q	8.84%
Earnings	Oct 27 BMO
EPS/Sales Surpr.	3.88% 1.53%

Insider Own	1.00%
Insider Trans	-6.89%
Inst Own	102.22%
Inst Trans	-1.38%
ROA	4.70%
ROE	23.01%
ROIC	6.83%
Gross Margin	26.02%
Oper. Margin	13.90%
Profit Margin	8.09%
SMA20	4.78%
SMA50	6.04%
SMA200	33.45%
Trades

Shs Outstand	164.60M
Shs Float	162.96M
Short Float	1.97%
Short Ratio	2.19
Short Interest	3.22M
52W High	277.40 0.33%
52W Low	154.50 80.14%
Volatility	3.62% 3.05%
ATR (14)	7.99
RSI (14)	64.72
Beta	1.17
Rel Volume	1.14
Avg Volume	1.47M
Volume	1,672,438

Perf Week	2.69%
Perf Month	3.91%
Perf Quarter	33.78%
Perf Half Y	73.21%
Perf YTD	23.47%
Perf Year	27.75%
Perf 3Y	50.97%
Perf 5Y	8.34%
Perf 10Y	276.01%
Recom	1.42
Target Price	304.71
Prev Close	276.63
Price	278.32
Change %	0.61%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-26	Resumed	UBS	Buy	$345
Jun-17-26	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$200
Mar-09-26	Upgrade	TD Cowen	Hold → Buy	$213
Mar-06-26	Upgrade	Barclays	Equal Weight → Overweight	$210
Mar-03-26	Initiated	RBC Capital Mkts	Outperform	$221
Dec-02-25	Resumed	Morgan Stanley	Overweight	$265
Nov-13-25	Initiated	BMO Capital Markets	Outperform	$260
Nov-03-25	Downgrade	TD Cowen	Buy → Hold	$215
Oct-29-25	Upgrade	Robert W. Baird	Neutral → Outperform	$258
Oct-09-25	Upgrade	HSBC Securities	Hold → Buy	$235
Sep-09-25	Upgrade	Jefferies	Hold → Buy	$225
Apr-25-25	Downgrade	HSBC Securities	Buy → Hold	$160
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight	$170
Feb-03-25	Downgrade	BTIG Research	Buy → Neutral
Dec-20-24	Initiated	Stephens	Overweight	$250
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-04-24	Initiated	RBC Capital Mkts	Outperform	$275
Jul-24-24	Downgrade	Jefferies	Buy → Hold	$266 → $242
Jun-06-24	Initiated	Goldman	Buy	$270
Feb-26-24	Initiated	Leerink Partners	Outperform	$290

Show Previous Ratings

Oct-13-26 07:03AM	IQVIA Selects Veeva Clinical Operations Applications (PR Newswire)
Oct-09-26 10:19AM	Could You Have Seen The Run In Tempus AI Stock Coming? (Trefis)
Oct-07-26 04:15PM	IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes (Business Wire)
04:15PM	IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions (Business Wire)
Sep-29-26 04:15PM	IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026 (Business Wire)
09:25AM	Loading…
Sep-24-26 09:25AM	Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year? (Trefis)
Sep-09-26 05:13PM	IQVIA Announces Pricing of Senior Notes (Business Wire)
08:15AM	IQVIA Announces Offering of Senior Notes (Business Wire)
Sep-03-26 04:15PM	IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster (Business Wire)
Sep-02-26 12:24PM	Beyond The Cloud Giants: What Could Power NVIDIA Stock From Here? (Trefis)
Aug-27-26 08:19PM	Amgen Stock Signals Its Confidence. The Market Agrees. (Trefis)
04:15PM	IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare (Business Wire)
Aug-24-26 02:23PM	What Is Really Moving Tempus AI Stock Right Now? (Trefis)
Aug-20-26 04:15PM	IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year (Business Wire)
Aug-17-26 04:15PM	IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group (Business Wire)
08:01AM	Loading…
Aug-13-26 08:01AM	This Healthcare Services Stock Has 37% Upside (Barrons.com)
Aug-12-26 03:17PM	Amgen Stock And The Price Of A Promise (Trefis)
Aug-06-26 12:30PM	IQVIA, Medera Partner to Accelerate Development of Cardiac Gene Therapies (Exec Edge)
Aug-04-26 04:15PM	IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery (Business Wire)
Jul-28-26 05:00PM	IQVIA Holdings Inc (IQV) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and AI-Driven ... (GuruFocus.com) +13.94%
01:49PM	IQVIA Holdings Inc. Q2 2026 Earnings Call Summary (Moby)
12:44PM	This Healthcare Stock Is Today's Best in the S&P 500 (Barrons.com)
07:14AM	IQVIA: Q2 Earnings Snapshot (Associated Press)
07:00AM	IQVIA Reports Second-Quarter 2026 Results (Business Wire)
Jul-16-26 01:39PM	IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States (Business Wire)
Jul-08-26 04:15PM	IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026 (Business Wire)
Jun-24-26 04:30PM	IQVIA Holdings Inc. stock outperforms competitors on strong trading day (MarketWatch) +8.37%
Jun-17-26 09:47AM	Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls (The Fly)
09:13AM	Morgan Stanley favors Charles River Over IQVIA in CRO sector reset (Investing.com)
Jun-15-26 09:00AM	Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain (Business Wire)
10:51AM	Loading…
Jun-04-26 10:51AM	IQVIA Announces Pricing of Senior Notes (Business Wire)
08:38AM	Is Veeva Stock Undervalued At $170? (Trefis)
Jun-03-26 02:53AM	IQVIA Announces Offering of Senior Notes (Business Wire)
May-28-26 04:30PM	IQVIA Holdings Inc. stock outperforms competitors on strong trading day (MarketWatch) +9.34%
May-26-26 04:15PM	IQVIA CEO to Speak at Jefferies Global Healthcare Conference (Business Wire)
May-13-26 04:30PM	IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities (Business Wire)
May-07-26 05:15PM	IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization (Business Wire)
May-06-26 04:15PM	IQVIA CFO to Speak at Bank of America Health Care Conference 2026 (Business Wire)
May-05-26 12:51PM	IQVIA Holdings Inc. Q1 2026 Earnings Call Summary (Moby) +9.62%
07:14AM	IQVIA: Q1 Earnings Snapshot (Associated Press)
07:00AM	IQVIA Reports First-Quarter 2026 Results (Business Wire)
Apr-24-26 11:46AM	Eli Lilly Stock Falls. Foundayo Is Fighting to Catch Novo's Wegovy Pill. (Barrons.com)
Apr-15-26 04:15PM	IQVIA to Announce First-Quarter 2026 Results on May 5, 2026 (Business Wire)
04:05PM	Lilly Stock Dips on FDA Request for More Foundayo Safety Data. Is the Market Reaction Overblown? (Barrons.com)
Mar-16-26 04:30PM	IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences (Business Wire)
Mar-10-26 02:38PM	IQVIA Holdings Inc. (IQV) Advances Clinical Research and Data Capabilities to Drive Growth (Insider Monkey)
10:01AM	Is IQVIA Holdings Stock Underperforming the Nasdaq? (Barchart)
Mar-09-26 09:33AM	Netflix resumed, Starbucks downgraded: Wall Street's top analyst calls (The Fly)
Mar-04-26 10:08AM	Jim Cramer on IQVIA: "I Like the Business Very Much, I Just Don't Know Whether This Is the Right Stock to Play It" (Insider Monkey)
Mar-03-26 09:33AM	MongoDB downgraded, Block upgraded: Wall Street's top analyst calls (The Fly)
Mar-02-26 04:30PM	IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference (Business Wire)
04:15PM	IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference (Business Wire)
12:13PM	Can AI Acceleration and R&D Strength Drive VEEV Ahead of Q4 Earnings? (Zacks)
Mar-01-26 04:24AM	Analysts at Mizuho Remain Bullish on IQVIA (IQV) Following Q4 Results (Insider Monkey)
Feb-27-26 04:47PM	IQVIA Releases its 2025 Sustainability Report (Business Wire)
Feb-26-26 11:53PM	Is IQVIA Holdings Inc. (IQV) a Buy Post Earnings? (Insider Monkey) +5.39%
09:03AM	IQVIA Holdings (IQV) Rallied on Waning Concerns Over Biotech Funding and Clinical Activity (Insider Monkey)
06:42AM	IQVIA to acquire Charles River drug discovery assets (Pharmaceutical Technology)
Feb-25-26 11:08PM	3 Reasons to Sell IQV and 1 Stock to Buy Instead (StockStory)
09:06AM	Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans (Benzinga)
07:00AM	IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities (Business Wire)
Feb-24-26 02:33PM	IQVIA Holdings Inc. (IQV) Offers Impressive Upside Despite AI-Linked Threats (Insider Monkey)
Feb-21-26 10:39AM	Morgan Stanley Lowers its Price Target on IQVIA Holdings Inc. (IQV) to $240 but Maintains an Overweight Rating (Insider Monkey)
Feb-19-26 10:36AM	TransUnion Stock Gains 6% Post Reporting Q4 Earnings & Revenue Beat (Zacks)
05:38AM	Is Wall Street Bullish or Bearish on IQVIA Holdings Stock? (Barchart)
Feb-18-26 04:15PM	IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day (Business Wire)
09:15AM	Unlocking IQVIA (IQV) International Revenues: Trends, Surprises, and Prospects (Zacks)
Feb-17-26 11:46AM	Waste Connections Stock Slides 7% Since Q4 Earnings Beat Estimates (Zacks)
Feb-13-26 08:32AM	Is the Options Market Predicting a Spike in IQVIA Stock? (Zacks)
Feb-12-26 12:30PM	Insperity Stock Price Decreases 18% After Reporting Loss in Q4 (Zacks)
12:36AM	The Top 5 Analyst Questions From IQVIA's Q4 Earnings Call (StockStory)
Feb-11-26 07:19PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Feb-10-26 08:00AM	IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions (Business Wire) -5.30%
Feb-08-26 08:39AM	Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? (Benzinga)
Feb-06-26 07:21PM	IQVIA Q4 Earnings Call Highlights (MarketBeat)
09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)
12:54AM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
12:35AM	IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis (StockStory)
Feb-05-26 04:00PM	IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) -10.65%
12:11PM	IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y (Zacks)
11:55AM	IQVIA (IQV) Stock Trades Down, Here Is Why (StockStory)
09:07AM	IQVIA backs AI strategy as analysts question impact on business (Reuters)
08:15AM	IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates (Zacks)
07:36AM	IQVIA's (NYSE:IQV) Q4 CY2025 Sales Top Estimates (StockStory)
07:20AM	IQVIA: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance (Business Wire)
Feb-04-26 11:40AM	IQV or IDXX: Which Is the Better Value Stock Right Now? (Zacks)
Feb-03-26 10:14PM	IQVIA (IQV) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory) -11.88%
11:23AM	IQVIA Set to Report Q4 Earnings: Here's What You Should Know (Zacks)
09:15AM	Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics (Zacks)
Jan-29-26 08:00AM	IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration (Business Wire)
Jan-25-26 11:44AM	Beyond Biotech-3 Healthcare Stocks for Growth-Minded Investors (MarketBeat)
Jan-22-26 04:05PM	IQVIA Named to the Fortune Worlds Most Admired Companies List, Ranked No. 1 in Its Sector for Fifth Consecutive Year (Business Wire)
Jan-20-26 04:45PM	IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026 (Business Wire)
Jan-15-26 09:36AM	3 Medical Device Companies in Focus for Monetizing Data and Analytics (Zacks)
Jan-14-26 09:50AM	Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term (Zacks)
Jan-13-26 09:11AM	What You Need To Know Ahead of IQVIAs Earnings Release (Barchart)
Jan-12-26 11:36PM	2 Large-Cap Stocks Worth Your Attention and 1 We Turn Down (StockStory)
Jan-11-26 11:04PM	3 Reasons to Sell IQV and 1 Stock to Buy Instead (StockStory)
Jan-09-26 09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Berkshire James G.	See Remarks	Sep 02 '26	Option Exercise	131.82	5,381	709,323	13,558	Sep 04 05:00 PM
Berkshire James G.	See Remarks	Sep 02 '26	Sale	261.33	2,668	697,228	10,890	Sep 04 05:00 PM
JAMES G BERKSHIRE	Officer	Sep 02 '26	Proposed Sale	261.32	2,668	697,215		Sep 02 04:11 PM
STAUB W RICHARD	See Remarks	Aug 03 '26	Sale	232.68	5,500	1,279,740	13,312	Aug 04 05:00 PM
Patel Bhavik	See Remarks	Jul 31 '26	Sale	235.27	1,855	436,426	1,348	Aug 04 05:00 PM
WALTER STAUB	Officer	Aug 03 '26	Proposed Sale	232.68	5,500	1,279,740		Aug 03 04:14 PM
Sherbet Eric	See Remarks	Jul 29 '26	Sale	249.16	5,000	1,245,800	20,999	Jul 31 05:04 PM
Cherofsky Keriann	See Remarks	Jul 29 '26	Sale	245.21	558	136,827	2,989	Jul 31 05:03 PM
BOUSBIB ARI	See Remarks	Jul 29 '26	Option Exercise	78.21	156,206	12,216,871	992,147	Jul 31 05:02 PM
BOUSBIB ARI	See Remarks	Jul 29 '26	Sale	245.51	106,279	26,092,072	885,868	Jul 31 05:02 PM
BHAVIK PATEL	Officer	Jul 31 '26	Proposed Sale	235.27	1,855	436,426		Jul 31 04:04 PM
KERIANN CHEROFSKY	Officer	Jul 29 '26	Proposed Sale	245.21	558	136,827		Jul 29 04:10 PM
ERIC SHERBET	Officer	Jul 29 '26	Proposed Sale	249.16	5,000	1,245,775		Jul 29 04:07 PM
ARI BOUSBIB	Officer	Jul 29 '26	Proposed Sale	245.50	106,279	26,091,897		Jul 29 04:04 PM
BOUSBIB ARI	See Remarks	Dec 18 '25	Option Exercise	59.90	50,000	2,995,000	857,163	Dec 19 05:00 PM
BOUSBIB ARI	See Remarks	Dec 18 '25	Sale	222.43	36,564	8,132,931	820,599	Dec 19 05:00 PM
ARI BOUSBIB	Officer	Dec 18 '25	Proposed Sale	222.43	36,564	8,132,876		Dec 18 05:41 PM
Sherbet Eric	See Remarks	Oct 29 '25	Option Exercise	131.82	10,000	1,318,200	31,108	Oct 31 05:01 PM
Sherbet Eric	See Remarks	Oct 29 '25	Sale	219.70	4,000	878,800	27,108	Oct 31 05:01 PM
BOUSBIB ARI	See Remarks	Oct 29 '25	Option Exercise	59.90	77,592	4,647,761	884,755	Oct 31 05:00 PM
BOUSBIB ARI	See Remarks	Oct 29 '25	Sale	220.33	56,557	12,461,119	828,198	Oct 31 05:00 PM
ARI BOUSBIB	Officer	Oct 29 '25	Proposed Sale	220.33	56,557	12,460,983		Oct 29 04:18 PM
ERIC SHERBET	Officer	Oct 29 '25	Proposed Sale	219.70	4,000	878,820		Oct 29 04:10 PM

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission-critical information, technology solutions, and real-world evidence services to the company's life sciences clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial-related services. The Contract Sales and Medical Solutions segment offers healthcare provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1950 and is headquartered in Durham, NC.

CEO & ChairmanMr. Ari Bousbib

Executive VPMr. Eric M. Sherbet J.D.

President of Research & Development SolutionsMr. W. Richard Staub III

President of Commercial SolutionsMr. Alistair Grenfell

Executive VP & Chief Financial OfficerMr. Michael J. Fedock MBA

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IQV

IQVIA Holdings Inc

Upgrade your Finviz experience